New research from Emory University evaluated immune responses after the 2023–24 COVID vaccine. The study, published in Science and Translational Medicine, followed 24 participants for six months and measured memory B cells, binding antibodies, and neutralizing antibodies. The 2023–24 vaccine was monovalent and designed to match the then-dominant Omicron XBB.1.5 variant; previous vaccines had been bivalent.
Laboratory tests showed the vaccine produced antibodies with a half-life of more than 500 days, so at least half remained detectable more than 16 months after vaccination. Participants also produced cross-reactive antibodies that recognized both the ancestral WA1 strain and XBB.1.5. The researchers said immune imprinting likely contributed to a 2.8-fold increase in these cross-reactive antibodies.
The paper notes that SARS-CoV-2 has caused more than 1.2 million deaths nationwide and has many mutations. It also lists groups at higher risk of severe disease, such as people with cancer, autoimmune disorders, stroke, obesity, and existing heart, kidney, lung, or liver conditions.
Difficult words
- memory B cells — White blood cell that remembers past infections
- binding antibodies — Protein that binds to a virus or germ
- neutralizing antibodies — Antibody that can stop a virus infecting cells
- monovalent — Designed to target one strain or variant
- bivalent — Designed to target two different strains together
- half-life — Time for half of a substance to disappear
- immune imprinting — When first immune exposure shapes later responses
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Which of the risk groups named in the article would you put first for vaccine access in your community, and why?
- If antibodies remain detectable for many months, how might that change people’s plans for booster shots?
- How would you feel about a vaccine made to match a single dominant variant versus one that targets two variants? Explain briefly.
Related articles
Ancestral healing in the Caribbean
Ancestral healing asks societies to face historical wounds so people can live healthier lives. In the Caribbean, educators combine shamanic practices, nervous-system work and cultural rituals with scientific findings about trauma and community care.
RSV can cause long-term problems after hospital care
A study found that adults hospitalised with respiratory syncytial virus (RSV) often had lasting problems. Many patients experienced breathlessness and trouble with daily activities for months, and some stayed unwell for up to a year.
Calorie restriction improves muscle insulin response in old rats
In 24-month-old rats, eating 35% less for eight weeks changed many muscle proteins and improved insulin-stimulated glucose uptake. Males and females showed different molecular responses, and two proteins may be targets for diabetes treatment.